Mersana Therapeutics

formerly MersanaIPO

Targeted Therapies for Children and Adults

Public · Cambridge, United States · Founded 2001 · $136.1M raised

Employees
51–200
Founded
2001
Business Model
B2B
Total Funding
$136.1M
Last Round
$33.0M Series CJun 2016
Rounds
6
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Mersana Therapeutics was a clinical-stage biopharmaceutical company focused on antibody-drug conjugates and cancer research. Day One Biopharmaceuticals completed its acquisition of Mersana on January 6, 2026, adding Emi-Le to Day One's oncology pipeline for patients of all ages. The former Mersana site now presents Day One's targeted-therapy work, and subsequent announcements describe Day One becoming part of Servier's rare oncology portfolio.

Summary

Mersana Therapeutics is a Biotech company based in Cambridge, United States, founded in 2001. It has raised $136.1M in total across 6 rounds, most recently a $33.0M Series C round in Jun 2016. Investors include New Enterprise Associates, Wellington Management and Pfizer Ventures.

Tech & App Stack

10 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJun 2017
$75.0M

Sign up to see all 8 events

Funding: Venture Round through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mersana Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/mersana-therapeutics"><img src="https://indexed.vc/api/badge/company/mersana-therapeutics" alt="Mersana Therapeutics on Indexed.vc" width="260" height="76" /></a>